Raymond James & Associates Atara Biotherapeutics, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$0.44 - $1.22 $132 - $366	300 Added 1.53%	19,891 $13,000
Q4 2023 Jan 16, 2024	SELL	$0.23 - $1.74 $39,111 - $295,888	-170,051 Reduced 89.67%	19,591 $9,000
Q3 2023 Oct 24, 2023	BUY	$1.41 - $2.31 $3,238 - $5,306	2,297 Added 1.23%	189,642 $280,000
Q2 2023 Jul 25, 2023	SELL	$1.5 - $3.04 $2,337 - $4,736	-1,558 Reduced 0.82%	187,345 $301,000
Q1 2023 Apr 14, 2023	BUY	$2.8 - $5.46 $20,132 - $39,257	7,190 Added 3.96%	188,903 $547,000
Q4 2022 Feb 08, 2023	SELL	$2.85 - $5.18 $7,481 - $13,597	-2,625 Reduced 1.42%	181,713 $596,000
Q3 2022 Oct 25, 2022	BUY	$2.85 - $8.73 $339,477 - $1.04 Million	119,115 Added 182.63%	184,338 $697,000
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $305,895 - $641,794	65,223 New	65,223 $508,000
Q2 2020 Jul 28, 2020	SELL	$7.53 - $14.93 $179,003 - $354,915	-23,772 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$5.69 - $17.78 $14,828 - $46,334	2,606 Added 12.31%	23,772 $202,000
Q4 2019 Feb 12, 2020	BUY	$10.89 - $16.79 $10,149 - $15,648	932 Added 4.61%	21,166 $349,000
Q3 2019 Nov 07, 2019	SELL	$12.03 - $19.94 $2,682 - $4,446	-223 Reduced 1.09%	20,234 $286,000
Q2 2019 Aug 06, 2019	SELL	$19.05 - $41.04 $103,917 - $223,873	-5,455 Reduced 21.05%	20,457 $411,000
Q1 2019 May 06, 2019	BUY	$28.4 - $41.74 $5,594 - $8,222	197 Added 0.77%	25,912 $1.03 Million
Q4 2018 Feb 11, 2019	SELL	$30.9 - $42.97 $9,733 - $13,535	-315 Reduced 1.21%	25,715 $893,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $13,143 - $16,312	-375 Reduced 1.42%	26,030 $1.08 Million
Q2 2018 Aug 14, 2018	SELL	$35.15 - $51.45 $53,674 - $78,564	-1,527 Reduced 5.47%	26,405 $970,000
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $46,926 - $126,048	2,607 Added 10.29%	27,932 $1.09 Million
Q4 2017 Feb 14, 2018	BUY	$13.2 - $18.1 $22,690 - $31,113	1,719 Added 7.28%	25,325 $458,000
Q3 2017 Nov 13, 2017	BUY	$13.25 - $17.05 $159 - $204	12 Added 0.05%	23,606 $391,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,594	23,594 $330,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account